AnaBioTec is a pioneering analytical service provider in the biotechnology industry. The company, founded in 1983 and headquartered in Belgium, specializes in Small Molecules, Biologics & Cell & Gene Therapy solutions. With over 20 years of experience in analytical method development and validation, AnaBioTec offers invaluable insight during CMC activities for product development and filing. Their experienced scientific project managers play a crucial role in mitigating risks, accelerating timelines, and addressing complex formulation challenges. The company's extensive expertise encompasses DS, liposomal products, low solubility products, microspheres, and derivatized products. Despite the absence of recent disclosed investments and associated investors, AnaBioTec's steadfast commitment to cutting-edge analytical solutions makes it a noteworthy candidate for potential venture capital consideration within the biotechnology and analytics startup space.
There is no investment information
No recent news or press coverage available for AnaBioTec.